US FDA seeks feedback to draft guidelines on product classification
This article was originally published in Clinica
The US FDA has issued for public consultation two related draft guidelines on product classification issues including classifying medical products as drugs or devices and interpreting the term "chemical action" in the context of medical devices.
You may also be interested in...
The final guidance adds some requested clarifications, but does not appear to address the US agency's tendency to designate products as drugs over devices, industry attorneys argue.
US FDA's tendency to designate products as drugs over devices may remain despite clarifications offered in final guidance.
Whoever takes over as chair of the Medicines and Healthcare products Regulatory Agency will play a key role in its plans to deliver a program of “ambitious business change.”